The company also plans to renew marketing and development of its
brachytherapy products for the treatment of cancer, which include Prospera
brachytherapy seeds and SurTrak needles, and strands used primarily in the treatment
of prostate cancer.
In addition, NAS will continue with plans to commercialize its ClearPath
multichannel catheter breast brachytherapy devices in 2007.
By AuntMinnie.com staff writers
August 3, 2007
calls in new BatCam, July 23, 2007
receives Premier renewal, July 2, 2007
taps Rush as president, CEO, March 23, 2007
revenues edge up, but loss widens in Q1, March 15, 2007
trims year-end losses, January 12, 2007
Copyright © 2007 AuntMinnie.com